Fuso Pharmaceutical Industries,Ltd. had a revenue of 15.41B in the quarter ending Dec 31, 2023, with 10.70%. This bring the company's revenue in the last twelve months to 54.63B, Decreased 2.94%. In the fiscal year ending Mar 31, 2024, Fuso Pharmaceutical Industries,Ltd. had annual revenue of 55.41B with 8.61% growth.